Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1. (Q43204655)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 December 2009

Language	Label	Description	Also known as
English	Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1.	scientific article published on 30 December 2009

Statements

scholarly article

1 reference

Europe PubMed Central

16 November 2017

Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1. (English)

1 reference

Europe PubMed Central

16 November 2017

1 reference

based on heuristic

inferred from title

1

object named as

Mitja Lainscak

1 reference

Europe PubMed Central

16 November 2017

author name string

Alison P Coletta

2

1 reference

Europe PubMed Central

16 November 2017

Nasser Sherwi

3

1 reference

Europe PubMed Central

16 November 2017

John G F Cleland

4

1 reference

Europe PubMed Central

16 November 2017

publication date

30 December 2009

1 reference

Europe PubMed Central

16 November 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

16 November 2017

12

1 reference

Europe PubMed Central

16 November 2017

2

1 reference

Europe PubMed Central

16 November 2017

193-196

1 reference

Europe PubMed Central

16 November 2017

Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction -- a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Galectin-3: a novel mediator of heart failure development and progression

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Low-dose dopamine: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Renal Vasodilatory Action of Dopamine in Patients With Heart Failure: Magnitude of Effect and Site of Action

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Stem cell therapy for heart failure: are arrhythmias a real safety concern?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Improving the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting: The IMPROVE HF performance improvement registry

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP185

21 January 2018

Identifiers

10.1093/EURJHF/HFP185

1 reference

Europe PubMed Central

16 November 2017

1 reference

Europe PubMed Central

16 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43204655&oldid=1598260374"